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H-2 I-region encoded determinants are thought to be expressed on very few tissues 
including lymphocytes, macrophages, sperm, epidermal, and endothelial cells. Yet, I- 
region disparate allografts are rejected; not only skin (1), the epidermal ceils of which 
are known to express Ia antigens, but other organs (2) as well. Suqh data have been 
used to argue indirectly (2) that I-region encoded determinants, which are capable of 
serving as targets in allograft rejection, may be present on organ parenchymal cells. 
A critical examination of this question is important because in allografl systems in 
which donor and recipient differ for the entire major histocompatibility complex, the 
fact that allografts are rejected does not necessarily prove the presence of parenchymal 
cell  targets.  Evidence obtained ,using  other transplant  models  has  shown  that  the 
presence of allogeneic passenger leukocytes in otherwise presumably syngeneic trans- 
plants, i.e., where there are no parenchymal cell target determinants foreign to the 
recipient,  can  result  in  graft  rejection  (3-6).  Thus,  mere  rejection of an  allograft 
cannot be used to argue critically that there are parenchymal cell determinants that 
play a role in the rejection process. 
The majority of fresh thyroid grafts are rejected in recipients which differ from the 
donor by the H-2 I  region. In contrast, thyroids taken from donors pretreated with 
lymphocytotoxic drugs and x rays and then cultured for 10 d  (cultured thyroids) are 
not rejected by any recipient, presumably due to depletion of passenger leukocytes. 
We have used transplantation of cultured thyroid lobes beneath the kidney capsule 
(7)  to  obtain  direct  evidence  for  the  presence  of I-region  encoded  parenchymal 
antigens  which  can  function  as  targets  in  graft  rejection.  Lafferty et  al.  (7)  have 
previously demonstrated  that  parenchymal  cells  of cultured  thyroids  carry  target 
determinants because sensitization of the recipient with lymphoid cells syngeneic with 
the cultured thyroid results in rejection of that thyroid. Those experiments (which we 
have confirmed using cultured thyroids obtained by the protocol given in Methods), 
however, are most easily interpreted as indicating the presence of K/D-region encoded 
determinants  on  the  parenchymal  cells  since  donor and  recipient  differed by  the 
entire H-2 complex. 
The results presented here provide evidence for the existence of I-region encoded 
parenchymal cell antigens that can function as targets in allograft rejection because 
recipients presensitized to I-region different spleen cells will specifically reject cultured 
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TABLE I 
Fate of Fresh Thyroid Allografls Transplanted between AQR, BIO.AQR, and 
BIO. T(6R) 
Fresh thyroid donor  Recipient  Ratio* in individual animals 
AQR  B10.AQR  44.2, 267.1, 26.7, 317.8, 
89.6, 249.8 
BI0.T(6R)  BI0.T(6R)  80.0, 175.0, 38.5 
B 10.AQR  B 10.T(6R)  1.1, 1.1, 20.4 
BI0.T(6R)  BI0.AQR  1.0, 1.0, I5.8, 0.9 
* Ratio  of counts per  minute  of ~2nI incorporated  as detailed  in  Methods 
determined on day 132 after transplantation  as described in Methods. 
thyroids syngeneic with the sensitizing strain. These data extend our present concepts 
regarding the tissue distribution of I-region encoded gene products. 
Materials  and Methods 
Preparation of Cultured Thyroids.  Fresh  thyroid lobes  are  transplanted  beneath  the  kidney 
capsule (7) of recipients which have been radiologically thyroideetomized 3 wk previously with 
100 #Ci tstI. Alternatively, the donor may receive lymphocytotoxic pretreatment of 300 mg/kg 
cyclophosphamide on day 2 and day 1 plus  1,000-R gamma radiation before thyroid removal; 
the thyroid is then placed in organ culture for 10 d in an atmosphere of 95% 02-5% Co2 before 
transplantation. 1 Cultured thyroids obtained by this protocol behave identically to long-term 
cultured thyroids (7, 8). That is, they show essentially indefinite survival in allogeneie recipients. 
Presensitization.  Thyroidectomized recipient mice are sensitized 7 d-6 mo before transplan- 
tation by intraperitoneal administration of 50-80 ×  l0  s spleen cells. 
Functional Assay.  The  viability  of a  thyroid  graft  is  assayed  as  follows.  The  transplant 
recipient is given 5.0 #Ci carrier free t2sI intraperitoneally. 24-48 h after injection, the recipient 
is anesthetized and the counts per minute emitted by the thyroid are evaluated by placing a 
gamma probe (components by Ortec Inc. E. G. & G., Inc., Oak Ridge, Tenn.)  first  over the 
kidney containing the thyroid and then over the contralateral control kidney. The total counts 
are expressed as a  ratio of counts in the kidney containing the graft to those of the control 
kidney. A ratio which approaches one indicates graft nonfunction. The viability of the graft 
can thus be determined from the day of transplantation  until termination of the experiment. 
Alternatively, 24 h after intraperitoneal administration of 12~I, the kidneys are placed in tubes 
of 10% buffered formalin for counting in a conventional gamma counter and for histological 
preparation.  Excellent  correlations  exist  among data  obtained  with  the gamma probe,  the 
conventional gamma well  counter, and histological appearance of thyroids with ratios >4.0 
correlating with normal thyroid morphology. Ratios given represent  the averages of multiple 
animals tested per group. 
Mice.  Mice used in these experiments were bred in our own colony except that B10.AQR 
mice were a gift from Dr. James Finke (Cleveland, Ohio). H-2 genotypes for K, I-A, I-B, I-J, I- 
E,  I-C, S, and  D  are:  AQR(B10.AQR)  qkkkkddd;  B10.T(6R)  qqqqqqqd;  B10.A kkkkkddd; 
B 10.BR  kkkkkkkk; B 10.A(4R)  kkbbbbbb; B 10.A(2R)  kkkkkddb; C57BL/10 bbbbbbb; A.TH 
sssssssd; and A.TL skkkkkkd. 
Results 
Fresh  thyroids transplanted  in the AQR-B10.T(6R)  or B10.AQR-B10.T(6R)  com- 
binations  are  usually  rejected,  although  not  all  thyroids  are  rejected  reciprocally. 
Shown  in  Table  I  are  results  from one of seven  different  experiments,  all  yielding 
similar data, showing rejection in the great majority of these allografts, however, with 
some long-term surviving thyroid lobes. Variable results after skin allografting in this 
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TABLE II 
Specific Rejection of I-Region Disparate Cultured Thyroids in Recipients Presensitized 7 d 
before Transplantation 
Line  Cultured nor  thyroid do-  Recipient  Donor of  cells  sensitizing  Ratio* 
a  AQR  B 10.T(6R)  AQR  1.0 
b  AQR  B 10.T(6R)  B 10.T(6R)  9.1 
c  B 10.T(6R)  B 10.T(6R)  B 10.T(6R)  11.8 
d  B 10.T(6R)  B 10.T(6R)  AQR  16.6 
B 10.BR  B 10.T(6R)  AQR  1.3 
B 10.BR  B 10.T(6R)  B I0.T(6R)  14.1 
g  B 10.T(6R)  AQR  B 10.T(6R)  1.0 
h  B 10.T  (6R)  AQR  --  56.4 
i  C57BL/10  AQR  B 10.T(6R)  48.3 
j  A.TH  A.TL  A.TL  249.5 
k  A.TH  A.TL  A.TH  1.0 
l  B 10.BR  A.TL  A.TH  106.2 
* Ratio of counts per minute of 1z5I incorporated as detailed in Methods. Assays  for data in 
lines a throughfperformed at 4 wk and lines g through i 7 wk after transplantation to final 
recipient. Results obtained in presensitized recipients are similar at any time of assay 3 wk 
after transplantation, i.e., rejection takes place before 3 ~vk and no instances of recovery have 
been observed as late as 15 wk. 
genetic  combination  have been  previously reported  (1).  In addition,  in  some cases, 
transplanted  fresh thyroids show periods of nonfunction for more than 4 wk followed 
by recovery and excellent  function.  Thyroids transplanted  in the A.TH-A.TL com- 
bination behave similarly. 
The cultured thyroid can be used as one model to ask, in vivo, whether parenchymal 
cells carry I-region target determinants.  A  cultured thyroid is not rejected even in H- 
2 disparate recipients, presumably because passenger leukocytes are no longer present. 
Shown in Table II are results of experiments in which cultured thyroids transplanted 
into recipients presensitized  7 d earlier to spleen cells syngeneic with the thyroid donor 
are rejected, suggesting the presence of I-region encoded targets on thyroid parenchy- 
mal cells.  An AQR cultured  thyroid transplanted  to a  6R recipient  presensitized  to 
AQR cells is rejected (line a) and vice versa (line g). In contrast, AQR or 6R cultured 
thyroids transplanted to control 6R recipients receiving 6R cells (lines b, and c) or 6R 
cultured  thyroids  transplanted  to  6R  recipients  sensitized  with  AQR  cells  (line  d) 
show highly significant function. Likewise, 6R cultured thyroids transplanted to AQR 
recipients  that  have not been presensitized  (line h)  show excellent  function.  Similar 
results were obtained when recipients were presensitized  6 wk before transplantation 
(data not shown). 
In  some  experiments,  the  AQR  strain  used  was  not  fully  congenic  with  the 
background  of the  6R  strain.  Thus,  additional  combinations  were  tested  to  ask 
whether rejection of the cultured thyroid grafts in the presensitized recipients was, in 
fact, due to H-2 I-region encoded determinants.  Cultured thyroids from donors of the 
B10.BR strain, which shares the H-2 I-A, I-B, I-J, and I-E subregions with AQR and 
is congenic with 6R were rejected by 6R recipients presensitized to AQR cells (line e). 
Cultured  B10.BR thyroids transplanted  to control 6R recipients  presensitized  to 6R 
cells  were  not  rejected  (line  f).  Since  the  B10.BR  thyroid  shares  the  non-H-2 
background genes with the 6R recipient and presents essentially the same I region to 
6R as AQR, rejection is most likely related  to the I-region determinants.  In order to GOSE  AND  BACH  BRIEF  DEFINITIVE  REPORT  1257 
TABLE III 
Acceptance off-Region  Disparate Cultured Thyroids in the B IO.A (2R)- 
B I O.A ( 4R) Combination Despite Presensitization 
Donor of sensitiz-  Cultured thyroid  Recipient  Ratio* 
donor  ing cells 
2R  4R  4R  29.0 
2R  4R  2R  19.9 
4R  4R  2R  22.8 
4R  4R  4R  79, 2 
* Ratio  of counts per  minute  of 12sI incorporated  as  detailed  in  Methods 
determined on day 30. 
further help rule out non-H-2-1oci encoded target determinants  in rejection by AQR 
of I-region  disparate  6R cultured  thyroids, C57BL/10 euhured  thyroids were trans- 
planted to AQR recipients that had been presensitized with 6R cells. If the rejection 
of 6R cultured thyroids by AQR recipients presensitized to 6R cells were due to non- 
H-2  encoded  antigens,  then  AQR  recipients  presensitized  to  6R  cells  should  be 
sensitized to those differences and reject the cultured C57BL/10 thyroids, which does 
not occur (line i). 
Similar  findings,  demonstrating  the  presence of I-region  encoded  target  determi- 
nants  on thyroid  parenchymal  cells have been obtained  in  the A.TH-A.TL  combi- 
nation.  A,TL  animals  presensitized  to  A.TL  cells  do  not  reject  a  cultured  A.TH 
thyroid (line j), whereas A.TL recipients presensitized to A.TH do reject the cultured 
A.TH thyroid  (line k). As a specificity control, A.TL presensitized  to A.TH does not 
reject a cultured, K-region disparate,  B 10.BR thyroid  (line l). 
In seven different experiments testing survival of cultured thyroid grafts in these I- 
region  disparate  combinations,  40 out of 42 cultured  thyroid  lobes transplanted  to 
allogeneic recipients presensitized  to leukocytes syngeneic with the thyroid donor (as 
in lines a, g, and k of Table II) were rejected (all ratios <2.5); in contrast, only 2 of the 
23 cultured  thyroid  lobes transplanted  to allogeneic  recipients  not  presensitized,  or 
"presensitized" with leukocytes syngeneic with the recipient,  (as in lines b, h, andj of 
Table II) failed to show function. 
In contrast  to findings with  the AQR-6R combination  discussed above are those 
obtained  in similar experiments  using the B10.A(2R)  and  B10.A(4R)  strains  which 
differ in the I-B, I-J, I-E, I-C, and S regions, but not in I-A. These strains do not reject 
each other's  thyroids and  reciprocal  sensitization  does not  lead to graft  rejection or 
delays in the onset of function  (see Table III). 
Discussion 
The  findings  that  (a)  both 6R and  AQR animals  presensitized  to AQR and  6R 
cells  respectively  reject  cultured  thyroids  of the  sensitizing  genotype,  (b)  that  6R 
animals  presensitized  to AQR cells reject  cultured  B10.BR thyroids,  and  (c)  AQR 
recipients sensitized to 6R do not reject C57BL/I0 cultured thyroids (which share the 
background  with 6R)  suggest strongly that  thyroid parenchymal  cells have I-region 
encoded  target  antigens.  This  finding  is supported  by the  studies  using  the  A.TL- 
A.TH combination. Furthermore, the finding that 4R and 2R mice do not reciprocally 
reject under similar conditions  implies the existence of I-A-subregion encoded deter- 
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such as Qa, or for non-MHC  genes, which are involved in these phenomena, must 
always be considered. 
Despite the presumed presence on the parenchymal cells of determinants that can 
function as targets in the presensitized animal, these antigens on a  cultured thyroid 
are  apparently  not  immunogenic for cells  that  can  mediate graft  rejection since a 
cultured thyroid is not rejected. It has been suggested (2) that heart fragment rejection 
in I-region disparate strains argues for the presence of immunogenic, I-region encoded 
determinants on the heart parenchymal cells; we think it more likely that  immuni- 
zation by transplanted organs is dependent on the presence of passenger leukocytes 
or, perhaps, on some interaction between the response to passenger leukocytes and the 
parenchymal cell target antigens. 
Because  presensitized  animals  can  recognize parenchymal  cell  I-region encoded 
targets on the thyroid lobe does not prove that these determinants have a role in graft 
rejection; even if they play a part in second-set graft rejection, this does not necessarily 
extend to first-set reactions. We have, however, obtained some preliminary data which 
suggest  that  parenchymal antigens may be important in graft destruction. When a 
cultured thyroid is passaged under the kidney capsule of an intermediate host for 8 d 
or more, and then transplanted to a final recipient whose lymphoid cells recognize K/ 
D  differences on  the  parenchymal  cells  of the  thyroid  and  I-region  antigens  on 
passenger leukocytes acquired from the intermediate host, one observes the fibrotic 
sequelae of severe parenchymal cell damage which we have not seen under similar 
conditions when the thyroid donor and final recipient are syngeneic. Whether this, 
too, will apply to I-region parenchymal targets is presently under investigation. 
Summary 
Fresh  thyroids  transplanted  to  I-region  disparate  recipients  are,  in  most  cases, 
rejected;  in  some  instances  fresh  thyroids  undergo  periods  of crisis  followed  by 
functional recovery. Cultured thyroids that are taken from donor animals pretreated 
with lymphocytotoxic drugs, gamma radiation and cultured for lO d in vitro are not 
rejected by any normal allogenic recipient. If the recipient is sensitized with lymphoid 
cells syngeneic with an I-region disparate cultured thyroid donor, the cultured thyroid 
is rejected if I-A-subregion differences are included. We interpret these data to indicate 
that there exist I-region encoded perenchymal cell target determinants which are not, 
by themselves, immunogenic. 
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